Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01220401 · ClinicalTrials.gov registry record · NA

Efficacy of a Brief Nightmare Treatment for Veterans

A NA study of PTSD and Suicide, sponsored by University of Tul.

Completed
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT01220401 is a NA study of PTSD and Suicide that has completed, run by University of Tul. The registered enrollment target is 21 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01220401, a NA study of PTSD and Suicide, has completed, sponsored by University of Tul.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to find out what effects Exposure, Rescripting, and Relaxation Therapy (ERRT) has on nightmares and associated problems in veterans.

Interventions

  • BEHAVIORAL exposure, relaxation, and rescription therapy

Study Locations (1)

Oklahoma

  • The University of Tulsa - Tulsa

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2010-10
Est. Completion 2011-08
Phase NA

Sponsor

University of Tul

5 total trials

What the Registry Record Tells You About NCT01220401

The ClinicalTrials.gov registry entry for NCT01220401 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (93% lower). The listed sponsor is University of Tul, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which exposure, relaxation, and rescription therapy is the first listed.

NCT01220401 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT01220401 about?

NCT01220401 is a clinical study titled "Efficacy of a Brief Nightmare Treatment for Veterans". The purpose of this study is to find out what effects Exposure, Rescripting, and Relaxation Therapy (ERRT) has on nightmares and associated problems in veterans.

What is the current status of trial NCT01220401?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2010-10. Estimated completion is 2011-08.

What conditions does trial NCT01220401 study?

This clinical trial studies the following conditions: PTSD, Suicide, Sleep Disorders.

What interventions are being tested in trial NCT01220401?

The interventions under investigation include: exposure, relaxation, and rescription therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01220401?

This trial is sponsored by University of Tul, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01220401 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.